Acquisition of a Majority Stake by Eurofins, a Leading Global Analytical Company, and Strengthening of Business under Eurofins Group
Repertoire Genesis Inc. (Headquarter: Ibaraki City, Osaka, Japan) is pleased to announce that, pursuant to an agreement with Eurofins (Eurofins Scientific SE), a global leader in analytical and testing services with one of the world's leading laboratory network, Eurofins has completed its acquisition of a majority stake in the Repertoire Genesis, making it a member of the Eurofins group.
With the mission of "Curing the Incurable", Repertoire Genesis integrates a large amount of information obtained from its proprietary immune diversity analysis technology to accurately understand biological immune reactions from multiple perspectives, thereby contributing to the unprecedented new medical developments (basic research, prevention, diagnosis, and treatment) applying the immune system in a wide range of disease fields, including cancer, autoimmune diseases, and infectious diseases.
As a member of the Eurofins Group, a world leader in analytical/testing services, Repertoire Genesis will combine Eurofins' diverse and cutting-edge analytical menu supporting drug/diagnostic development, access to pharmaceutical companies on a global level, abundant group resources, and know-how in laboratory operations, with our own TCR/BCR repertoire analysis and other immune diversity analysis technologies, intellectual property rights, know-how and research network. Repertoire Genesis will accelerate the elucidation of mechanisms of various diseases involving the immune system and development of new diagnostic methods and treatments, and contribute to the realization of human health around the world.
[About Eurofins Group]
Eurofins is a global leader in analytical and contracts research services in food, environmental, pharmaceutical, cosmetics, and agrochemistry, with more than 900 laboratories and 58,000 staff in 54 countries around the world. The group also offers laboratory services in support of genomics, pharmacology, forensic science, drug development and manufacturing, materials science, and clinical research.
For the press release from Eurofins, please click here.
[For further information & contact]
Administrative department, Repertoire Genesis Inc.